Skip to main content
. 2019 Jan 7;79(2):161–171. doi: 10.1007/s40265-018-1043-y
The optimal fluoroquinolone dose should be investigated for tuberculosis treatment.
Patients at risk for a too low drug exposure should be selected and monitored.